caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1598752248

Ara MakdessianM.D.

OtolaryngologyWinchester, KYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
724
Unique beneficiaries
—
Total services
6,358
Distinct HCPCS
13
Medicare payment
$81K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 116 Otolaryngology providers in KY — top quintile (cohort median 890).
REFERRAL NETWORK

Where Ara Makdessian's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 9 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
SAINT JOSEPH HEALTH SYSTEM, INC4196
NPI 13068492942196
SAINT JOSEPH HEALTH SYSTEM, INC1968
New Lexington Clinic, Psc
Clinical Laboratory · Lexington, KY
1646
Labone Of Ohio Inc
Clinical Laboratory · Cincinnati, OH
1538
Worawute Supaongprapa
Pulmonary Disease · Pikeville, KY
1480
Taufik Kassis
Internal Medicine · Frenchburg, KY
1397
Larry Ertel
Internal Medicine · Saint Petersburg, FL
1382
Rezkalla Butros
Internal Medicine · Mt. Sterling, KY
12101
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
4,539
Beneficiaries
—
Total drug cost
$127K
Distinct drugs
21
Brand share
4.4%
Top prescribed drugs
Levocetirizine Dihydrochloride1,500 claims
Fluticasone Propionate947 claims
Montelukast Sodium742 claims
Azelastine Hcl395 claims
Pantoprazole Sodium234 claims
QUALITY · MIPS · 2024
Final MIPS score
0.0
Quality
0.0
Cost
0.0
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
-9.00%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$21
Payment records
1
By payment type
Food and Beverage$21